These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3001410)
21. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. Simpson RU; Thomas GA; Arnold AJ J Biol Chem; 1985 Jul; 260(15):8882-91. PubMed ID: 2991224 [TBL] [Abstract][Full Text] [Related]
22. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells. Petkovich PM; Heersche JN; Tinker DO; Jones G J Biol Chem; 1984 Jul; 259(13):8274-80. PubMed ID: 6330107 [TBL] [Abstract][Full Text] [Related]
24. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Tanaka H; Abe E; Miyaura C; Kuribayashi T; Konno K; Nishii Y; Suda T Biochem J; 1982 Jun; 204(3):713-9. PubMed ID: 6289803 [TBL] [Abstract][Full Text] [Related]
25. A receptor-like binding macromolecule for 1 alpha, 25-dihydroxycholecalciferol in cultured mouse bone cells. Chen TL; Hirst MA; Feldman D J Biol Chem; 1979 Aug; 254(16):7491-4. PubMed ID: 468767 [TBL] [Abstract][Full Text] [Related]
26. Specific cytosol binding proteins for 25(OH)D3 and 1.25(OH)2D3 in human breast cancers. Nakata M; Tsuboi S; Takenaka M; Konishi Y; Kawashima R; Tomita M; Nakagawa T; Iwamura N; Fujita T Endocrinol Jpn; 1981 Dec; 28(6):741-6. PubMed ID: 6286292 [TBL] [Abstract][Full Text] [Related]
27. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells. Freake HC; Iwasaki J; McCarthy DM Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655 [TBL] [Abstract][Full Text] [Related]
28. Association of 1,25-dihydroxyvitamin D3 with cultured 3T6 mouse fibroblasts. Cellular uptake and receptor-mediated migration to the nucleus. Pike JW; Haussler MR J Biol Chem; 1983 Jul; 258(14):8554-60. PubMed ID: 6305993 [TBL] [Abstract][Full Text] [Related]
29. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor. Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380 [TBL] [Abstract][Full Text] [Related]
30. Hormonal responses to 1,25-dihydroxyvitamin D3 in cultured mouse osteoblast-like cells--modulation by changes in receptor level. Chen TL; Li JM; Ye TV; Cone CM; Feldman D J Cell Physiol; 1986 Jan; 126(1):21-8. PubMed ID: 3003120 [TBL] [Abstract][Full Text] [Related]
31. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648 [TBL] [Abstract][Full Text] [Related]
32. 1,25-Dihydroxyvitamin D3 binds specifically to rat vascular smooth muscle cells and stimulates their proliferation in vitro. Koh E; Morimoto S; Fukuo K; Itoh K; Hironaka T; Shiraishi T; Onishi T; Kumahara Y Life Sci; 1988; 42(2):215-23. PubMed ID: 2826956 [TBL] [Abstract][Full Text] [Related]
33. The ovary: a target organ for 1,25-dihydroxyvitamin D3. Dokoh S; Donaldson CA; Marion SL; Pike JW; Haussler MR Endocrinology; 1983 Jan; 112(1):200-6. PubMed ID: 6291916 [TBL] [Abstract][Full Text] [Related]
34. 1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat. Klaus G; Merke J; Eing H; Hügel U; Milde P; Reichel H; Ritz E; Mehls O Calcif Tissue Int; 1991 Nov; 49(5):340-8. PubMed ID: 1664276 [TBL] [Abstract][Full Text] [Related]
35. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues. Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482 [TBL] [Abstract][Full Text] [Related]
36. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor. Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280 [TBL] [Abstract][Full Text] [Related]
37. Binding and metabolism of 1,25-dihydroxyvitamin D3 in cultured bovine parathyroid cells. Brown AJ; Berkoben M; Ritter CS; Slatopolsky E Endocrinology; 1992 Jan; 130(1):276-81. PubMed ID: 1309332 [TBL] [Abstract][Full Text] [Related]
38. Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone. Gross M; Kost SB; Ennis B; Stumpf W; Kumar R J Bone Miner Res; 1986 Oct; 1(5):457-67. PubMed ID: 2845731 [TBL] [Abstract][Full Text] [Related]
39. I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse. Seino Y; Sierra RI; Ichikawa M; Avioli LV Endocrinology; 1982 Jul; 111(1):329-31. PubMed ID: 6282570 [TBL] [Abstract][Full Text] [Related]
40. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Dokoh S; Donaldson CA; Haussler MR Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]